固尔苏联合经鼻持续气道正压通气治疗新生儿呼吸窘迫综合征疗效分析

Treatment of Neonatal Respiratory Distress Syndrome with Gasol Combined Nasal Continuous Positive Airway Pressure Ventilation

目的对出现呼吸窘迫综合征的新生儿采用固尔苏与经鼻持续气道正压通气联合治疗的方式进行治疗,分析其临床治疗效果和血气指标的变化情况。方法选择2015年2月至2017年2月期间在我院接受治疗的64例呼吸窘迫综合征新生儿患儿,随机将患儿分成两组,对照组32例,观察组32例。对照组患儿采用固尔苏和机械通气联合治疗的方式进行治疗,观察组患儿采用固尔苏与经鼻持续气道正压通气联合治疗的方式进行治疗,查看两组患儿的治疗效果,并查看患儿血气指标的变化情况。结果经过治疗对比,观察组患儿的治愈率显著高于对照组患儿,且观察组患儿的氧分压和动脉血氧饱和度显著高于对照组患儿,观察组患儿的住院时间和吸氧时间显著少于对照组患儿,二氧化碳分压明显低于对照组患儿(P<0.05)。结论对出现呼吸窘迫综合征的新生儿采用固尔苏与经鼻持续气道正压通气联合治疗的方式进行治疗,有利于患儿患儿症状,提高治疗有效率,安全可靠,值得临床推广应用。

Objective To treat neonates with respiratory distress syndrome who were treated with Gul-Su and nasal continuous positive airway pressure ventilation,and to analyze their clinical effects and changes of blood-gas indexes.Methods A total of 64 newborns with respiratory distress syndrome who were treated in our hospital from February 2015 to February 2017 were randomly divided into two groups:control group(32 cases)and observation group(32 cases).Children in the control group were treated with Gul-Su and mechani-cal ventilation.The children in the observation group were treated with Gul-Su and nasal continuous positive airway pressure ventilation,and the therapeutic effects of the two groups were observed,And check the changes of children’s blood gas index.Results After treatment,the cure rate in observation group was signifi-cantly higher than that in control group,and the oxygen partial pressure and arterial oxygen saturation in obser-vation group were significantly higher than those in control group.The hospitalization of children in observation group The time and the time of oxygen inhalation were significantly less than those of the control group,and the partial pressure of carbon dioxide was significantly lower than that of the control group(P<0.05).Conclusion The treatment of neonatal respiratory distress syndrome with the combination therapy of Curel and nasal contin-uous positive airway pressure is beneficial to the treatment of children with symptoms,improve the treatment ef-ficiency,safety and reliability,and worthy of clinical promotion application.